Short Interest in Bioxytran, Inc. (OTCMKTS:BIXT) Rises By ∞

Bioxytran, Inc. (OTCMKTS:BIXT) was the target of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 130 shares, an increase of ∞ from the July 30th total of 0 shares. Based on an average daily volume of 183,704 shares, the short-interest ratio is presently 0.0 days. Currently, 0.0% of the shares of the company are sold short.

Bioxytran Price Performance

Shares of BIXT opened at $0.02 on Monday. The firm has a market cap of $2.59 million, a PE ratio of -0.75 and a beta of 1.99. The stock’s fifty day moving average price is $0.02 and its two-hundred day moving average price is $0.03. Bioxytran has a 1 year low of $0.02 and a 1 year high of $0.09.

Bioxytran (OTCMKTS:BIXT) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.01) EPS for the quarter.

About Bioxytran

Bioxytran, Inc is a clinical-stage biotechnology company focused on the development of synthetic oxygen carriers and novel oxygen therapeutics for acute care and chronic disease applications. The company’s proprietary platform is designed to safely deliver therapeutic levels of oxygen to hypoxic tissues, addressing conditions such as ischemia-reperfusion injury, organ transplantation, and traumatic injury. Its lead product candidates target unmet medical needs in cardiovascular and neurological disorders, wound healing, and critical care settings.

Bioxytran’s research pipeline comprises multiple preclinical-stage assets that leverage stabilized perfluorocarbon emulsions to achieve controlled oxygen release.